ARCHIVES

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Tucson Conference Could Be Lively

February 16, 1979

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

March 18, 1994